T. Rowe Price Investment Management, Inc. 13D and 13G filings for MorphoSys AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-16 4:57 pm Sale | 2023-12-31 | 13G | MorphoSys AG MOR | T. Rowe Price Investment Management, Inc. | 6,431,063 4.300% | -2,712,552 (-29.67%) | Filing |
| 2024-02-14 10:04 am Purchase | 2023-12-31 | 13G | MorphoSys AG MOR | T. Rowe Price Investment Management, Inc. | 9,143,615 4.300% | 1,865,517 (+25.63%) | Filing |
| 2023-02-14 12:40 pm Purchase | 2022-12-31 | 13G | MorphoSys AG MOR | T. Rowe Price Investment Management, Inc. | 7,278,098 5.300% | 7,278,098 (New Position) | Filing |